Recursion Pharmaceuticals, Inc. · NASDAQ:RXRX
Borgeson Blake sold 30,000 Recursion Pharmaceuticals, Inc. shares (Form 4)
Traded Aug 4, 2026 · Filed Aug 6, 2026
On Aug 4, 2026, Borgeson Blake (Director) sold 30,000 Recursion Pharmaceuticals, Inc. shares at US$3.25 for US$97,500 under a trading plan, leaving 6,188,287 shares. Filed Aug 6, 2026 (Form 4).
- Sold
- 30,000 shares
- Price
- US$3.25
- Value
- US$97,500
- Holding after
- 6,188,287 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Director
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Aug 4, 2026 | Class A Common Stock | Sale | 30,000 | US$3.25 | 6,188,287 | Direct |
Source
Related
- Recursion Pharmaceuticals, Inc.
- Borgeson Blake
- Recursion Pharmaceuticals, Inc. shareholders
- Form 4 · Borgeson Blake · Oct 7, 2026
- Form 4 · Borgeson Blake · Sep 2, 2026
- Form 4 · Borgeson Blake · Jul 9, 2026
- Form 4 · Borgeson Blake · Jun 22, 2026
- Form 4 · Borgeson Blake · Jun 4, 2026
- Form 4 · Hershberg Robert · Oct 7, 2026
- Form 4 · Dar Zavain · Oct 2, 2026
- Form 4 · Li Dean Y · Oct 2, 2026
- Form 4 · Taylor Ben R · Sep 16, 2026
- Form 4 · Khan Najat · Sep 10, 2026